GeneLink Statistics
Total Valuation
GeneLink has a market cap or net worth of 10,601.
| Market Cap | 10,601 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
GeneLink has 265.02 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 265.02M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +2.16% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.20% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.34
| Current Ratio | 0.34 |
| Quick Ratio | 0.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.05 |
| Interest Coverage | -6.51 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -69.12% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 229.76% |
| Revenue Per Employee | 112,789 |
| Profits Per Employee | -159,090 |
| Employee Count | 14 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 3.33 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -186.62 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 40.65 |
| Average Volume (20 Days) | 1,025 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.00 |
Income Statement
In the last 12 months, GeneLink had revenue of 1.58 million and -2.23 million in losses. Loss per share was -0.01.
| Revenue | 1.58M |
| Gross Profit | 306,402 |
| Operating Income | -2.20M |
| Pretax Income | -2.23M |
| Net Income | -2.23M |
| EBITDA | -2.11M |
| EBIT | -2.20M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 127,559 in cash and 1.19 million in debt, giving a net cash position of -1.06 million or -0.00 per share.
| Cash & Cash Equivalents | 127,559 |
| Total Debt | 1.19M |
| Net Cash | -1.06M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -3.20M |
| Book Value Per Share | -0.01 |
| Working Capital | -1.47M |
Cash Flow
In the last 12 months, operating cash flow was -1.13 million and capital expenditures -4,505, giving a free cash flow of -1.14 million.
| Operating Cash Flow | -1.13M |
| Capital Expenditures | -4,505 |
| Free Cash Flow | -1.14M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 19.40%, with operating and profit margins of -139.47% and -141.05%.
| Gross Margin | 19.40% |
| Operating Margin | -139.47% |
| Pretax Margin | -141.05% |
| Profit Margin | -141.05% |
| EBITDA Margin | -133.36% |
| EBIT Margin | -139.47% |
| FCF Margin | n/a |
Dividends & Yields
GeneLink does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.57% |
| Shareholder Yield | -25.57% |
| Earnings Yield | -21,009.88% |
| FCF Yield | -10,715.00% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GeneLink has an Altman Z-Score of -36.74. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -36.74 |
| Piotroski F-Score | n/a |